Related Experiment Videos
Effectiveness of cefoperazone in treating cutaneous infections
Abstract:
Twenty-eight patients with severe cutaneous infections received cefoperazone, 2 grams intramuscularly twice a day for seven days. A wide range of gram-positive and gram-negative pathogens were isolated from admission cultures. All patients showed rapid clinical improvement. Two patients did not complete the full course of therapy because of intervening medical problems unrelated to the antibiotic. No significant side effects were noted. Relapses or reinfections occurred in two patients. In conclusions, cefoperazone is a safe and effective antibiotic for use in skin infections requiring parenteral therapy.
Insights
Cefoperazone effectively treated severe skin infections in 28 patients, showing rapid clinical improvement with no significant side effects. This parenteral antibiotic proved safe and effective for bacterial skin infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Dermatology
Background:
- Severe cutaneous infections pose significant clinical challenges.
- Effective parenteral antibiotic therapy is crucial for managing serious bacterial skin infections.
Purpose of the Study:
- To evaluate the safety and efficacy of cefoperazone in treating severe cutaneous infections.
- To assess the clinical outcomes and side effect profile of cefoperazone therapy.
Main Methods:
- Twenty-eight patients with severe skin infections were enrolled.
- Cefoperazone was administered intramuscularly at a dose of 2 grams twice daily for seven days.
- Pathogen identification was performed using admission cultures.
Main Results:
- All patients demonstrated rapid clinical improvement.
- A broad spectrum of gram-positive and gram-negative pathogens were identified.
- No significant adverse effects were observed during the treatment course.
- Relapse or reinfection occurred in two patients.
Conclusions:
- Cefoperazone is a safe and effective antibiotic option for parenteral treatment of severe skin infections.
- The drug demonstrated a favorable safety profile and clinical efficacy in the studied patient cohort.
- Further investigation may be warranted for long-term outcomes and specific pathogen susceptibilities.